#NOVARTIS announced a massive #recall of over the counter pills on January 9, 2012. This recall applies to #EXCEDERIN, #BUFFERIN, #NODOZ and #GASX products. Emerging reports indicate that the facility, in Lincoln, Nebraska, where the pills were manufactured and packaged had failed repeated safety inspections by the FDA. Chips of different products were found in the wrong containers, indicative of a failure to ‘clear’ the manufacturing lines or machinery used for packaging. While this recall involves ‘over the counter’ medicines found in many households it should be taken seriously as a stray pill could lead to an allergic reaction or adverse event.
Of additional significance is the fact that, the FDA announced that ENDO PHARMACEUTICAL opiod products - or pain killers - should be carefully evaluated to confirm they are the intended prescription only product intended for consumers. Apparently, the prescription pain killers were also manufactured at the same facility and isolated incidents of confusion were reported, but averted, by pharmacists while filling prescriptions.
Refunds are available from Novartis by visiting the company website and following directions. Adverse events, allergic reactions or illness should be reported to the FDA and health authorities.
#NOVARTIS #recalls popular over the counter: #Excederin, #Bufferin #NoDoz, #GASX. Apparently, problems and mix ups relating to the over the counter meds during the manufacturing process precipitated the #recall. Details are still emerging. FDA is warning about related opiod meds made for ENDO and requesting patients and providers to scrutinize tablets.